These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 848252)

  • 1. [Porphyrin-protein complexes and participation of immune processes in the pathogenesis of porphyria].
    Zawirska B
    Acta Haematol Pol; 1977; 8(1):65-72. PubMed ID: 848252
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
    Baravalle E; Prieto J
    Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical medicine of disorders of porphyrin metabolism in man].
    Ghiringhelli P; Farfaglia P; Ghiringhelli L
    Minerva Med; 1987 Oct; 78(20):1495-517. PubMed ID: 3313115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hepatic porphyrias: pathogenesis, manifestations, and management.
    Bloomer JR
    Gastroenterology; 1976 Oct; 71(4):689-701. PubMed ID: 955357
    [No Abstract]   [Full Text] [Related]  

  • 5. [Porphyria hepatocutaneous tarda. Etiopathogenesis and physiopathologic treatment].
    Enríquez de Salamanca R
    An R Acad Nac Med (Madr); 1987; 104(4):523-37. PubMed ID: 3328526
    [No Abstract]   [Full Text] [Related]  

  • 6. [General considerations on the pathogenesis of porphyria].
    Enríquez de Salamanca R; Batlle AM
    Rev Clin Esp; 1990 Apr; 186(7):313-5. PubMed ID: 2203118
    [No Abstract]   [Full Text] [Related]  

  • 7. [New findings in hepatic porphyrias].
    Strohmeyer G
    Leber Magen Darm; 1972 Oct; 2(6):221-6. PubMed ID: 4660667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Porphyria cutanea tarda (chronic hepatic porphyria): new aspects on pathogenesis, diagnosis and therapy with a review of the workshop, "Cutaneous porphyrias" at the 17th World Congress of Dermatology in Berlin 1987].
    Doss MO
    Z Hautkr; 1988 Apr; 63(4):282-9. PubMed ID: 3291437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and therapy of hepatic porphyria].
    Doss MO
    Acta Med Austriaca; 1990; 17(5):94-9. PubMed ID: 2092571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of hepatic porphyrin synthesis in tissue culture by sera of patients with acute porphyria.
    Kappas A; Song CS; Sassa S; Levere RD
    Trans Assoc Am Physicians; 1969; 82():372-9. PubMed ID: 5375160
    [No Abstract]   [Full Text] [Related]  

  • 11. [Porphyria (review of the literature)].
    Idel'son LI
    Probl Gematol Pereliv Krovi; 1967 Mar; 12(3):36-46. PubMed ID: 4898326
    [No Abstract]   [Full Text] [Related]  

  • 12. [Symposium on clinical aspects on porphyrias. (3). Pathogenesis of hepatic porphyria].
    Wada O
    Nihon Naika Gakkai Zasshi; 1967 Sep; 56(9):960-4. PubMed ID: 5627156
    [No Abstract]   [Full Text] [Related]  

  • 13. Porphyria cutanea tarda. New facts on aetiology, pathogenesis clinical manifestations and treatment.
    Malina L; Chlumský J; Chlumská A
    Acta Univ Carol Med Monogr; 1974; (59):1-126. PubMed ID: 4616623
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the biochemical pathogenesis of acute intermittent porphyria].
    Heilmeyer L
    Munch Med Wochenschr; 1969 Apr; 111(16):905-9. PubMed ID: 5819143
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria.
    Wiegand SE
    J Med Assoc Ga; 1972 Mar; 61(3):99-106. PubMed ID: 4551367
    [No Abstract]   [Full Text] [Related]  

  • 16. [HLA antigen distribution and porphyria cutanea tarda--a contribution on the problem of the association of HLA with metabolic diseases].
    Gebhardt B; Köstler E; Seebacher C
    Dermatol Monatsschr; 1984; 170(8):506-10. PubMed ID: 6479408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Porphyrin metabolism, and clinical-laboratory comparative investigations in model studies and in patients with porphyria cutanea tarda].
    Simon N; Dobozy A; Berkó G
    Arch Klin Exp Dermatol; 1970; 238(1):38-43. PubMed ID: 5421921
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental and clinical studies on porphyria. Some considerations on the pathogenesis of hepatic porphyria].
    Wada O
    Nihon Naika Gakkai Zasshi; 1965 Oct; 54(7):763-72. PubMed ID: 5894804
    [No Abstract]   [Full Text] [Related]  

  • 19. The question of hepatic or ubiquitous versus erythropoietic origin of the excessive porphyrin in porphyria congenita erythropoietica.
    Watson CJ
    Panminerva Med; 1968 Mar; 10(3):110-3. PubMed ID: 5689830
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma proteins in liver diseases as a diagnostic parameters].
    Rösler-Englhardt A
    Med Welt; 1975 Nov; 26(47):2125-30. PubMed ID: 53773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.